Biotechnology

Haystack Oncology, an oncology company, uses the most recent circulating tumor DNA detection technology to enhance the diagnosis of minimum residual disease and provide superior therapy decision-making information.

Glycostem is a clinical stage biotech company developing off-the shelf allogeneic cellular immunotherapy using Natural Killer (NK) cells.

NMD Pharma is dedicated to developing novel treatments to improve muscle function and quality of life of patients with neuromuscular disease.

Akeso (HKEX: 09926) is a commercial-stage biopharmaceutical company committed to discovering, developing, manufacturing, and commercializing innovative medicines that address global medical needs. Since our inception, we have established a distinctive and integrated R&D innovation system with the co

Inventprise engages in cutting-edge research bringing incisive scientific insights and novel products to global populations in need of important, life-saving vaccines.

Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs).

Cathay Biotech (Cathay) is a global technology leader in synthetic biology and the use of bio-processes to produce new materials on an industrial scale.

The Global Coalition for Adaptive Research (GCAR) unites physicians, clinical researchers, advocacy and philanthropic organizations, biotech/pharma, health authorities, and other key stakeholders in healthcare to expedite the discovery and development of treatments for patients with rare and deadly

cytena GmbH has developed a device called cy-Clone to separate single cells. Single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research. The cy-Clone is supported by an automated

Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in the Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rar

Perimed AB is a Swedish company, founded in 1981 and headquartered just outside Stockholm. Perimed develops, manufactures and markets state-of-the-art diagnostic equipment to assess microcirculation and peripheral perfusion as well as Peripheral Arterial Disease. We offer solutions for clinical use

Visgenx develops therapeutics to protect against the loss of sight from retinal disorders. Its programs are based on increasing the expression of a gene known as ELOVL2 which may regulate aging in cells critical for vision.

Mekonos is a Silicon Valley Venture-backed technology company — creating a proprietary cell-engineering platform based on scalable silicon technology for our partners engaged in drug discovery and development.

We are convinced that early detection of diseases is the prerequisite for better treatment options and thus optimal chances of recovery. That is why we are driven by the vision of making chronic health imbalances diagnosable even before the disease can manifest itself. This is the prerequisite for

Versatope Therapeutics is an infectious disease company with two lead development programs and others at the preclinical stage. Versatope delivers immunity by customizing nano-size vesicles by using synthetic biology for biopharmaceutical applications.

ExThera Medical Corporation is developing revolutionary medical.

NanoString Technologies, Inc. is a publicly held biotech company that specializes in development of cancer diagnostics tools.

SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, is a U.S. biotech company focused on the discovery of transformative medicines through targeted protein degradation (TPD). We discover and develop therapies through precise degradation of disease-causing proteins. Our team takes a target-

Lazurite is a biotechnology company that creates the operating room of the future through smart surgical tools.

Longeveron is a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions.

Alterity is developing first-in-class therapies to treat neurodegenerative disease.

BioOne offers an online platform that features bioscience research and best practices from peers in the scientific circuit.

Our mission is to provide powerful tools that translate what is happening in a patients’ body into a readable and interpretable language. We call it our new language of life. The “language of life” makes it easier to understand, diagnose and treat chronic and metabolic diseases produced by the mo

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), is a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases. With world-class research and development capabilities, a highly productive scientific platform, and a proven managemen

Lolli lets you earn bitcoin when you shop online.

Navigator Medicines is a clinical-stage biopharmaceutical company leading the advancement of biologics for targeted immune regulation & restoration. Founded in 2024, as a subsidiary of Sera Medicines, through a $100M Series A financing, co-led by RA Capital Management and Forbion, the Company is com

HighTide Therapeutics, Inc. is a globally integrated biopharmaceutical company focusing on the discovery and development of first-in-class multifunctional therapies with poly-indications across metabolic and digestive diseases with significant unmet medical needs. The company is developing multiple

Eurogentec is a biotech company and trusted CDMO based in Belgium. Since 1985 we manufacture and deliver products for life science research, diagnostics and therapeutics markets.

Jurata Thin Film allows for the long-term storage of vaccines and biologics at room temperature or higher. Furthermore, therapeutic cargo stored in this thin film can be delivered via a variety of routes.

Concept Life Sciences is a knowledge-based, science-led and customer-focused contract research and manufacturing organisation with world-leading expertise in the pharmaceutical, biotech and agrochemical industries. We are based across 5 sites in the UK delivering discovery research as well as GMP

Greffex has invented the future of vaccines.

UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases.

Concentrics Research LLC offers Research and Development services in the Physical, Engineering, and Life Sciences (except Biotechnology)

At Pluton Biosciences we make novel microbes discovery commercially viable using our revolutionary Micromining Innovation Engine.

Kyfora Bio, the bioprocess business spin-off of Polysciences, Inc., is a leading provider of critical biochemicals supporting advanced drug discovery and development processes. Our extensive portfolio of polymer- and lipid-based transfection reagents, pharmaceutical excipients and various other inno

AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated tech

XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of pharmaceutical products for the treatment of unmet clinical needs. XTL is a public

Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics.

FUJIFILM VisualSonics designs and manufactures ultra high frequency ultrasound imaging systems, for both research and clinical use. FUJIFILM VisualSonics specifically focuses on developing ultrasound technology that has been scaled to much higher frequencies than commonly found in many of the con

Página Inicial

We are a world leader in gene analyses for a wide range of medical, research and pharmaceutical applications. Since 2009, we have been helping doctors and patients find the genetic causes of rare diseases. We provide researchers and pharmaceutical companies with genetic analysis for clinical trials

BodyBio is a nutritional supplement company that is relentlessly focused on the pursuit of health at the cellular level. Its founders are leading researchers in the field of complex metabolic disorders, fatty acid analysis, and the idea that cellular health is at the core of all health. With more th

Adamo Food is a UK-based food tech company developing plant-based whole-cut meats using proprietary fermentation technology combined with mycelium.

ALS Therapy Development Institute is dedicated to funding research to cure Amyotrophic lateral sclerosis disease.

GHIC is an impact investment firm that has been a pioneer in structuring, managing and investing in transformative funds to improve global health.

Annovis Bio develops novel treatments for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders.

The company was founded in 1977 by cardiovascular surgeon Full Professor Domingo Braile, precursor and creator in Brazil of bovine pericardium biological heart valves. Located in São José do Rio Preto, interior of São Paulo, the company has the status of research and promotion of national techno

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

The OmniAb discovery platform provides pharmaceutical industry partners with access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics. At the heart of the OmniAb platform is the Biological Intelligence (BI) of our proprieta

Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key unmet medical needs of serious musculoskeletal diseases. With the team’s experience and scientific expertise in new drug development, Angitia is dedicated to bringin